Trump administration unveils four executive orders aimed at lowering drug prices
WASHINGTON — The Trump administration unveiled four executive orders on Friday aimed at bringing down pharmaceutical prices — a last-ditch effort by the White House to cut drug costs before the November election, though it’s not clear how quickly the reforms can be finalized.
The most dramatic aspects of the announcement include a one-month ultimatum for drug manufacturers to propose alternative plans to reduce drug prices. If Trump remains unsatisfied, he said, his administration would revive a long-stalled plan to cap U.S. drug prices based on what drug makers charge in foreign countries.
